BLCM — Bellicum Pharmaceuticals Share News
0.000.00%
Last trade - 00:00- $0.95m
- -$4.96m
- $1.50m
U.S. STOCKS ON THE MOVE-Netflix, Newell, Comerica, Twitter, Ladder Capital, Carvana
U.S. STOCKS ON THE MOVE-Netflix, UnitedHealth, Comerica, Valeritas, Chinanet Online, Apellis Pharma
U.S. STOCKS ON THE MOVE-Tesla, Twitter, Roku, Chinanet Online, Bellicum Pharma
U.S. STOCKS ON THE MOVE-Netflix, Twitter, Newell Brands, Roku
Bellicum Pharmacuticals Inc: Falls on stock offering
U.S. STOCKS ON THE MOVE-Bed Bath & Beyond, L Brands, Deere, Bristol-Myers Squibb, Cyren
U.S. STOCKS ON THE MOVE-TechnipFMC, Cyren, Bed Bath & Beyond, Bristol-Myers Squibb
U.S. STOCKS ON THE MOVE-Bed Bath & Beyond, Bellicum Pharma, Cyren, Daqo New Energy
U.S. STOCKS ON THE MOVE-Bed Bath & Beyond, BlackRock, Novavax, Bellicum Pharmaceuticals, TechnipFMC
Bellicum Pharma: Investors, analysts bullish as FDA lifts hold on trial
U.S. RESEARCH ROUNDUP-Avexis, Burlington Stores, Prologis
Brief: Bellicum Announces Clinical Hold Lifted On U.S. Studies Of BPX-501
Bellicum Pharma: FDA lifts hold on U.S. trials of cancer drug
Brief: Bellicum Pharmaceuticals Reports Qtrly Loss Per Share $0.66
U.S. STOCKS ON THE MOVE-GE, Qualcomm, Spherix, Proteostasis, Alliance MMA, Vocera
U.S. STOCKS ON THE MOVE-GE, Qualcomm, Intel, Proteostasis, Spherix, Dick's Sporting
U.S. STOCKS ON THE MOVE-Qualcomm, GE, Proteostasis, Spherix, Advaxis, Athersys
Bellicum Pharma: Up on positive interim data
Brief: Bellicum Announces Interim Results Showing Low Rates Of Cancer Recurrence In Pediatric AML Patients Treated With BPX-501